Interestingly, ERK5 inhibition also sensitized EC cells to the toxicity induced by other DR ligands such as TNFα or FasL (Fig. 1C), indicating a role for ERK5 kinase activity in mediating the extrinsic apoptosis induced by DR agonists in cancer cells. This evidence concerns the gene FASLG and cancer.